News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
FROST PHILLIP MD ET AL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2022 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 30.9% stake in OPKO Health, Inc. |
| 06/09/2021 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 3.8% stake in Cocrystal Pharma, Inc. |
| 03/02/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/23/2020 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a |
| 12/10/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 10% stake in VECTOR GROUP LTD. |
| 11/01/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 34.2% stake in OPKO Health, Inc. |
| 10/18/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 0% stake in Castle Brands Inc. |
| 09/05/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 31.8% stake in Castle Brands Inc. |
| 04/24/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 35.3% stake in NON-INVASIVE MONITORING SYSTEMS, INC. |
| 03/22/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 35.7% stake in OPKO Health, Inc. |
| 03/20/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 35.7% stake in OPKO Health, Inc. |
| 02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 24.4% stake in Red Violet, Inc. |
| 12/27/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 4.8% stake in LADENBURG THALMANN FINANCIAL SERVICES INC. |
| 12/11/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 13.9% stake in VECTOR GROUP LTD. |
| 11/20/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 37.3% stake in OPKO Health, Inc. |
| 04/06/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 24.7% stake in Cogint, Inc. |
| 03/16/2018 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 32.6% stake in Castle Brands Inc. |
| 12/29/2017 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 6.2% stake in CHROMADEX CORPORATION |
| 12/27/2017 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 2.2% stake in ELOXX PHARMACEUTICALS, INC. |
| 12/22/2017 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 26.4% stake in Cogint, Inc. |
| 08/17/2017 |
SC 13D/A
| FROST PHILLIP MD ET AL reports a 7.6% stake in CHROMADEX CORPORATION |
| 02/09/2017 |
SC 13D/A
| Sevion Therapeutics, Inc. reports a 8.4% stake in SEVION THERAPEUTICS, INC. |
| 12/29/2016 |
SC 13D/A
| Tiger X Medical, Inc. reports a 28.5% stake in BioCardia, Inc. |
| 12/28/2016 |
SC 13D/A
| IDI, Inc. reports a 29.3% stake in Cogint, Inc. |
| 11/10/2016 |
SC 13D/A
| Tiger X Medical, Inc. reports a 32.7% stake in BioCardia, Inc. |
| 09/14/2016 |
SC 13D/A
| ChromaDex Corp. reports a 9.4% stake in CHROMADEX CORPORATION |
| 07/21/2016 |
SC 13D/A
| IDI, Inc. reports a 30.9% stake in IDI, Inc. |
| 05/18/2016 |
SC 13D/A
| IDI, Inc. reports a 33.3% stake in IDI, Inc. |
| 05/17/2016 |
SC 13D/A
| Tiger X Medical, Inc. reports a 65% stake in Tiger X Medical, Inc. |
|
|
|